Detalles de la búsqueda
1.
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force.
Value Health
; 26(2): 153-162, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754539
2.
Key enablers and barriers to implementing adaptive pathways in the European setting.
Br J Clin Pharmacol
; 85(7): 1427-1433, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849187
3.
Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.
Pharmacoepidemiol Drug Saf
; 26(12): 1442-1450, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28345151
4.
Benefit-risk reassessment of medicines: a retrospective analysis of all safety-related referral procedures in Europe during 2001-2012.
Pharmacoepidemiol Drug Saf
; 25(9): 1004-14, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27146035
5.
An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe.
Eur J Clin Pharmacol
; 71(10): 1237-44, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26204969
6.
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment.
Pharmacoeconomics
; 39(3): 275-285, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336320
7.
The use of nonrandomized evidence to estimate treatment effects in health technology assessment.
J Comp Eff Res
; 10(14): 1035-1043, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279114
8.
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies.
Appl Health Econ Health Policy
; 19(5): 625-634, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028672
9.
Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective.
Patient
; 13(2): 145-149, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31942698
10.
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.
Alzheimers Res Ther
; 12(1): 154, 2020 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208190
11.
Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs.
Clin Pharmacol Ther
; 105(3): 684-691, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30300938
12.
Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease.
Front Med (Lausanne)
; 6: 73, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31134200
13.
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
Clin Pharmacol Ther
; 105(5): 1148-1155, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29901216
14.
Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project.
J Alzheimers Dis
; 67(2): 495-501, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584137
15.
Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe.
Front Pharmacol
; 9: 280, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29636692
16.
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.
CNS Drugs
; 32(12): 1085-1090, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467744
17.
Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.
Drug Saf
; 38(5): 437-53, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25822400
18.
How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
BMJ
; 368: l6435, 2020 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31896539
19.
All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe.
Pharmacoecon Open
; 3(3): 419-422, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31328246
20.
The evolution of adaptiveness: balancing speed and evidence.
Nat Rev Drug Discov
; 17(12): 845-846, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29977052